Fadrozole
-
Fadrozole
structure -
-
CAS No:
102676-47-1
-
Formula:
C14H13N3
-
Chemical Name:
Fadrozole
-
Synonyms:
Benzonitrile,4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-;Imidazo[1,5-a]pyridine,benzonitrile deriv.;4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile;Fadrozole;131833-76-6
- Categories:
-
CAS No:
Description
Fadrozole is a potent, selective and nonsteroidal inhibitor of aromatase with an IC50 of 6.4 nM.
4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile is an imidazopyridine.|A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.
Safety Information
3439
20/21/22
22-24/25
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug Information
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)|Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones. (See all compounds classified as Aromatase Inhibitors.)|Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)
CGS 020286A
Fadrozole Use and Manufacturing
From the corresponding carboxylic acid compound in dichloroethane, in the presence of concentrated sulfuric acid, through the introduction of ammonia gas for aminolysis.
Antineoplastic
Computed Properties
Molecular Weight:223.27
XLogP3:2.1
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:1
Exact Mass:223.110947427
Monoisotopic Mass:223.110947427
Topological Polar Surface Area:41.6
Heavy Atom Count:17
Complexity:311
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Fadrozole
-
![China]()
CN
YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Learn More Other Chemicals
-
FADROZOLE HYDROCHLORIDE
102676-31-3
-
Imatinib mesylate
220127-57-1
-
4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile
236750-65-5
-
Temozolomide Formula
85622-93-1
-
Imatinib Formula
152459-95-5
-
N-Desmethyl Imatinib Formula
404844-02-6
-
actinomycin D Structure
50-76-0
-
Epirubicin hydrochloride Structure
56390-09-1
-
What is Daunorubicin hydrochloride
23541-50-6
-
What is Pirarubicin
72496-41-4